Futuximab Antibody
Sym004 is a therapeutic antibody mixture comprising futuximab and zatuximab, which bind distinct EGFR epitopes. This dual-targeting approach enhances antitumor efficacy and is investigated in preclinical in vitro and in vivo studies for oncology research, particularly in EGFR-driven cancers.
Product Specifications
Target
EGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
5.74 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
146.28 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040158-100 1x 100 µL
Cytokeratin 17 (E3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680017-500 1x 500 µL
Ep-CAM / CD326 (VU-1D9), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470198-500 1x 500 µL
Cytokeratin 18 (DA7), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details